After Hours Summary: Quiet session; CHRS +24.3% surging on FDA approval news; LT

After Hours Summary: Quiet session; CHRS +24.3% surging on FDA approval news; LTH -4.9% down on CFO resignation
After Hours Gainers:
Companies trading higher in after hours in reaction to earnings/guidance: None
Companies trading higher in after hours in reaction to news: CHRS +24.3% (FDA approval of UDENYCA ONBODY), LIAN +2.6% (asset purchase agreement selling to JNJ), BTBT +1% (to double size of fleet in 2024), CYTK +0.6% (to host investor call regarding results from SEQUOIA-HCM)
After Hours Losers:
Companies trading lower in after hours in reaction to earnings/guidance: None
Companies trading lower in after hours in reaction to news: LTH -4.9% (CFO resigning), LUNR -1.6% (CFO departing, names new COO, strategic partnership with SK firm), SVM -1.6% (takeover offer of OreCorp), GMM -0.9% (stock offering), AMZN -0.1% (FDA sends letter about potentially harmful active pharmaceutical ingredients)